Search Results - "Porceddu, S.V"

Distinct patterns of stomatitis with concurrent cetuximab and radiotherapy for head and neck squamous cell carcinoma by Pryor, D.I, Burmeister, E, Burmeister, B.H, Poulsen, M.G, Porceddu, S.V

“…Summary To describe the distinct patterns of severe anterior stomatitis seen with concurrent cetuximab and radiotherapy (RT) compared to chemoRT or altered…”
Get full text

Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma by Foote, M.C., McGrath, M., Guminski, A., Hughes, B.G.M., Meakin, J., Thomson, D., Zarate, D., Simpson, F., Porceddu, S.V.

“…Although advanced cutaneous squamous cell carcinoma (CSCC) is quite common, there are few prospective trials regarding its optimal management. This study…”
Get full text

1372TiP - A phase III, randomised, double-blind study of adjuvant cemiplimab versus placebo post-surgery and radiation in patients with high-risk cutaneous squamous cell carcinoma (CSCC) by Rischin, D., Fury, M.G., Lowy, I., Stankevich, E., Li, S., Han, H., Porceddu, S.V.

“…CSCC is the second most common skin cancer. While the surgical cure rate for CSCC is>95%, a proportion of pts are considered to have high-risk for recurrence…”
Get full text

A phase III, randomised, double-blind study of adjuvant cemiplimab versus placebo post-surgery and radiation in patients with high-risk cutaneous squamous cell carcinoma (CSCC) by Rischin, D., Fury, M.G., Lowy, I., Stankevich, E., Li, S., Han, H., Porceddu, S.V.

Get full text

Identification of an excellent prognosis subset of human papillomavirus-associated oropharyngeal cancer patients by quantification of intratumoral CD103+ immune cell abundance by Solomon, B., Young, R.J., Bressel, M., Cernelc, J., Savas, P., Liu, H., Urban, D., Thai, A., Cooper, C., Fua, T., Neeson, P., Loi, S., Porceddu, S.V., Rischin, D.

“…Accurate prognostic stratification of human papillomavirus-associated oropharyngeal cancers (HPV+OPSCC) is required to identify patients potentially suitable…”
Get full text

S10. The emerging role of biomarker profiling and functional imaging for guidance of head and neck cancer management by Porceddu, S.V.

Get full text

O25. Results of a prospective PET-guided management of the neck study in node positive head and neck squamous cell carcinoma (HNSCC) following curative radiotherapy with or without concurrent chemotherapy by Porceddu, S.V., Pryor, D.I., Doughton, J., Burmeister, E., Burmeister, B.H., Poulsen, M.G.

Get full text

Parotid-sparing Radiotherapy: Does it Really Reduce Xerostomia? by Ng, M.K., Porceddu, S.V., Milner, A.D., Corry, J., Hornby, C., Hope, G., Rischin, D., Peters, L.J.

“…Parotid-sparing radiotherapy (PSRT) was introduced for patients with selected head and neck cancer requiring bilateral upper-neck irradiation at our centre in…”
Get full text